HiberCell
PrivateLast Round
Series B
May 19, 2021
Total Funding Raised
$158.15M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
HiberCell operates in Healthcare & Life Sciences and is based in Roseville, Minnesota. Its latest recorded funding round was a Series B round in May 2021.
HiberCell is a biotechnology company that develops therapeutic agents targeting adaptive stress pathways and immune modulation to combat cancer treatment resistance, relapse, and metastasis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HiberCell Comparables
Compare HiberCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Oniria Therapeutics | 81% | |
| Bantam Pharmaceutical | 78% | |
| NMS Group | 74% |
For institutional investors. Book with your work email.
HiberCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 19, 2021 | ||||
| Debt | May 19, 2021 | ||||
| Series A | Feb 7, 2019 |
For institutional investors. Book with your work email.
HiberCell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series B |
| New York City Economic Development Corporation | Series A |
| Hercules Capital | Debt, Series B |
| Hillhouse Investment | Series A |
| Magnetic Ventures | Series B |
| Trinitas Capital Management | Series B |
| ARCH Venture Partners | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 48% MoM.
- Jul 25, 2026
Monthly visitors grew 199% MoM, reaching 1.6K.
For institutional investors. Book with your work email.
HiberCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HiberCell's valuation, stock price, and market status.
Is HiberCell a public or private company?
HiberCell is a private company.
What is the current stock price of HiberCell?
HiberCell is a private company, so its shares have no public market price. Caplight tracks HiberCell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HiberCell worth (valuation)?
Valuation information for HiberCell is not publicly available.
Can I buy HiberCell stock?
HiberCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HiberCell's last funding round?
HiberCell's most recent funding round was Series B on May 19, 2021.
Who are the main investors in HiberCell?
Key investors in HiberCell include Hercules Capital, Trinitas Capital Management, ARCH Venture Partners, Monashee Investment Management.
Will HiberCell IPO soon?
No public IPO plans have been announced for HiberCell.
How can I track HiberCell secondary market activity?
Caplight tracks bids, offers, and trades in HiberCell's shares on secondary markets.